Asthma and risk of bronchiectasis exacerbation: we still need more evidence

Gao Yong-hua, Guan Wei-jie, Chen Rong-chang, Zhang Guo-jun

Source: Eur Respir J 2016; 48: 1246-1247
Journal Issue: October
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Gao Yong-hua, Guan Wei-jie, Chen Rong-chang, Zhang Guo-jun. Asthma and risk of bronchiectasis exacerbation: we still need more evidence. Eur Respir J 2016; 48: 1246-1247

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Assessing the risk of future severe asthma exacerbations using CARAT questionnaire and lung function
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013


Asthma and bronchiectasis exacerbation
Source: Eur Respir J 2016; 47:1680-1686
Year: 2016



Risk factors of postoperative pulmonary complications in bronchial asthma and COPD patients
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016

Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014


Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?”
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013


Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016



Acute severe asthma: evidence-based management of asthma exacerbations
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008



Identifying patients at risk for future exacerbations of asthma: Development of a prediction model
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015

Acute exacerbations of COPD: The influence of comorbidities and chronic medication on mortality and exacerbation rate
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015


Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015

Clustering asthma and COPD provides new evidence for both “British” and “Dutch” hypotheses of COPD development
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013


Asthma exacerbations in relation to severe asthma
Source: Eur Respir Mon 2011; 51: 120-129
Year: 2011


Identification of factors associated with exacerbation risk in severe COPD: Multivariate analysis of the WISDOM study
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016


Cardiovascular risk assessment in COPD patients with severe exacerbation
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Characterisation of asthma patients with persistent airflow obstruction
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016


Prevalence and co-morbidity of asthma, chronic bronchitis and emphysema: a pan-European estimation
Source: Eur Respir J 2006; 28: Suppl. 50, 449s
Year: 2006

Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


Recurrent exacerbation of asthma: Characteristics of the patients and risk factors
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015

Emphysematous phenotype is an independent predictor for frequent exacerbation of chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014